Globus Medical (GMED) Tops Q1 EPS by 1c

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.29, $0.01 better than the analyst estimate of $0.28. Revenue for the quarter came in at $139.3 million versus the consensus estimate of $140.3 million.

Globus Medical reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance